359 related articles for article (PubMed ID: 31706934)
41. Risks of Multiple Skin Cancers in Organ Transplant Recipients: A Cohort Study in 2 Administrative Data Sets.
Wehner MR; Niu J; Wheless L; Baker LX; Cohen OG; Margolis DJ; Giordano SH; Shin TM
JAMA Dermatol; 2021 Dec; 157(12):1447-1455. PubMed ID: 34668933
[TBL] [Abstract][Full Text] [Related]
42. The burden of cutaneous disease in solid organ transplant recipients of color.
Kentley J; Allawh R; Rao S; Doyle A; Ahmad A; Nadhan K; Proby C; Harwood CA; Chung CL
Am J Transplant; 2021 Mar; 21(3):1215-1226. PubMed ID: 32659869
[TBL] [Abstract][Full Text] [Related]
43. Outcomes of melanoma in recipients of solid organ transplant.
Dapprich DC; Weenig RH; Rohlinger AL; Weaver AL; Quan KK; Keeling JH; Walsh JS; Otley CC; Christenson LJ
J Am Acad Dermatol; 2008 Sep; 59(3):405-17. PubMed ID: 18556089
[TBL] [Abstract][Full Text] [Related]
44. Management of non-melanoma skin cancer in immunocompromised solid organ transplant recipients.
Bangash HK; Colegio OR
Curr Treat Options Oncol; 2012 Sep; 13(3):354-76. PubMed ID: 22592596
[TBL] [Abstract][Full Text] [Related]
45. Incidence, risk factors, and preventative management of skin cancers in organ transplant recipients: a review of single- and multicenter retrospective studies from 2006 to 2010.
Mudigonda T; Levender MM; O'Neill JL; West CE; Pearce DJ; Feldman SR
Dermatol Surg; 2013 Mar; 39(3 Pt 1):345-64. PubMed ID: 23190408
[TBL] [Abstract][Full Text] [Related]
46. Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study.
Harwood CA; Leedham-Green M; Leigh IM; Proby CM
Arch Dermatol; 2005 Apr; 141(4):456-64. PubMed ID: 15837863
[TBL] [Abstract][Full Text] [Related]
47. Clinical and dermoscopic characteristics of melanomas on nonfacial chronically sun-damaged skin.
Jaimes N; Marghoob AA; Rabinovitz H; Braun RP; Cameron A; Rosendahl C; Canning G; Keir J
J Am Acad Dermatol; 2015 Jun; 72(6):1027-35. PubMed ID: 25824275
[TBL] [Abstract][Full Text] [Related]
48. The thickness of melanomas has decreased in central Italy, but only for thin melanomas, while thick melanomas are as thick as in the past.
Crocetti E; Caldarella A; Chiarugi A; Nardini P; Zappa M
Melanoma Res; 2010 Oct; 20(5):422-6. PubMed ID: 20679908
[TBL] [Abstract][Full Text] [Related]
49. Reexamining the Threshold for Reexcision of Histologically Transected Dysplastic Nevi.
Fleming NH; Egbert BM; Kim J; Swetter SM
JAMA Dermatol; 2016 Dec; 152(12):1327-1334. PubMed ID: 27542070
[TBL] [Abstract][Full Text] [Related]
50. Melanomas detected with the aid of total cutaneous photography.
Feit NE; Dusza SW; Marghoob AA
Br J Dermatol; 2004 Apr; 150(4):706-14. PubMed ID: 15099367
[TBL] [Abstract][Full Text] [Related]
51. A Multicenter Survey: How Do Transplant Dermatologists Monitor Organ Transplant Recipients With Nevi?
Özcan D; Seçkin D; Haberal M
Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):198-202. PubMed ID: 29528027
[TBL] [Abstract][Full Text] [Related]
52. Incidental melanomas detected in veterans referred to dermatology.
Hanson JL; Kingsley-Loso JL; Grey KR; Raju SI; Parks PR; Bershow AL; Warshaw EM
J Am Acad Dermatol; 2016 Mar; 74(3):462-9. PubMed ID: 26612677
[TBL] [Abstract][Full Text] [Related]
53. Skin surveillance of a U.K. paediatric transplant population.
Thomson MA; Suggett NR; Nightingale PG; Milford DV; Baumann U; Kelly DA; Moss C; Hill VA
Br J Dermatol; 2007 Jan; 156(1):45-50. PubMed ID: 17199565
[TBL] [Abstract][Full Text] [Related]
54. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.
Banky JP; Kelly JW; English DR; Yeatman JM; Dowling JP
Arch Dermatol; 2005 Aug; 141(8):998-1006. PubMed ID: 16103329
[TBL] [Abstract][Full Text] [Related]
55. Survival after cutaneous melanoma in kidney transplant recipients: a population-based matched cohort study.
Vajdic CM; Chong AH; Kelly PJ; Meagher NS; Van Leeuwen MT; Grulich AE; Webster AC
Am J Transplant; 2014 Jun; 14(6):1368-75. PubMed ID: 24730453
[TBL] [Abstract][Full Text] [Related]
56. Malignant melanoma in organ transplant recipients: incidence, outcomes, and management strategies: a review of literature.
Džambová M; Sečníková Z; Jiráková A; Jůzlová K; Viklický O; Hošková L; Göpfertovà D; Hercogová J
Dermatol Ther; 2016; 29(1):64-8. PubMed ID: 26460720
[TBL] [Abstract][Full Text] [Related]
57. Risk of basal cell carcinoma in Swedish organ transplant recipients: a population-based study.
Krynitz B; Olsson H; Lundh Rozell B; Lindelöf B; Edgren G; Smedby KE
Br J Dermatol; 2016 Jan; 174(1):95-103. PubMed ID: 26333521
[TBL] [Abstract][Full Text] [Related]
58. Risk factors and prevention strategies for cutaneous squamous cell carcinoma in transplant recipients.
Urso B; Kelsey A; Bordelon J; Sheiner P; Finch J; Cohen JL
Int J Dermatol; 2022 Oct; 61(10):1218-1224. PubMed ID: 35080249
[TBL] [Abstract][Full Text] [Related]
59. Frequency and characteristics of melanomas missed at a pigmented lesion clinic: a registry-based study.
Carli P; Nardini P; Crocetti E; De Giorgi V; Giannotti B
Melanoma Res; 2004 Oct; 14(5):403-7. PubMed ID: 15457097
[TBL] [Abstract][Full Text] [Related]
60. [Clinical epidemiologic data of malignant melanoma based on 1,368 patients of the Graz University Dermatology Clinic (1970-1989)].
Rieger E; Soyer HP; Kofler R; Hödl S; Smolle J; Richtig E; Kerl H
Wien Klin Wochenschr; 1991; 103(20):612-6. PubMed ID: 1763507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
